Tumorigenesis of papillary thyroid cancer is not BRAF-dependent in patients with acromegaly.
INTRODUCTION:Several studies have reported a high frequency of papillary thyroid cancer (PTC) in patients with acromegaly. The aim of this study was to determine the prevalence and predictors of thyroid cancer in patients with acromegaly and to investigate the frequency of the BRAFV600E mutation in...
Main Authors: | Hee Kyung Kim, Ji Shin Lee, Min Ho Park, Jin Seong Cho, Jee Hee Yoon, Soo Jeong Kim, Ho-Cheol Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4201528?pdf=render |
Similar Items
-
The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
by: Hee Kyung Kim, et al.
Published: (2020-09-01) -
False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
by: Se Hyun Paek, et al.
Published: (2017-11-01) -
BRAF in Papillary Thyroid Carcinoma
by: Salvatore Giovanni Lanzilotta, et al.
Published: (2007-01-01) -
Acromegaly and papillary thyroid carcinoma: A case series
by: Maryam Heidarpour, et al.
Published: (2019-01-01) -
Predicting Extrathyroidal Extension in Patients With Papillary Thyroid Microcarcinoma According to a BRAF Mutation
by: Doh Young Lee, et al.
Published: (2017-06-01)